Mass die-offs rising among farmed salmon
尽管目前全球仅有5000名婴幼儿使用该药，但罕见病药物的高定价模式，叠加长期持续给药的治疗需求，让Vosoritide的商业表现持续走高。2025年，该药销售额达9.27亿美元，同比增长26%，是BioMarin的核心商业化增长引擎。
。服务器推荐是该领域的重要参考
She said: "I think we have some very good [treatment] options, and we can usually find something that will suit everyone in amongst all of those options."
（三）对报案人、控告人、举报人、证人打击报复的；
Publication date: 28 February 2026